Climb Bio, Inc.
CLYM
$1.21
-$0.02-1.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.69M | 4.95M | 4.88M | 3.67M | 1.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.02M | 10.91M | 8.39M | 56.37M | 3.01M |
| Operating Income | -23.02M | -10.91M | -8.39M | -56.37M | -3.01M |
| Income Before Tax | -20.78M | -8.42M | -8.90M | -54.89M | -1.70M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.78M | -8.42M | -8.90M | -54.89M | -1.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.78M | -8.42M | -8.90M | -54.89M | -1.70M |
| EBIT | -23.02M | -10.91M | -8.39M | -56.37M | -3.01M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.31 | -0.13 | -0.13 | -1.81 | -0.06 |
| Normalized Basic EPS | -0.20 | -0.09 | -0.05 | -1.13 | -0.04 |
| EPS Diluted | -0.31 | -0.13 | -0.13 | -1.81 | -0.06 |
| Normalized Diluted EPS | -0.20 | -0.09 | -0.05 | -1.13 | -0.04 |
| Average Basic Shares Outstanding | 67.46M | 64.74M | 67.01M | 30.35M | 27.64M |
| Average Diluted Shares Outstanding | 67.46M | 64.74M | 67.01M | 30.35M | 27.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |